5-HYDROXY-LENALIDOMIDE

NC1=C(O)C=CC2=C1CN(C3CCC(=O)NC3=O)C2=O

InChIKey=XHIRLGUOUTXTHY-UHFFFAOYSA-N

InChI=1S/C13H13N3O4/c14-11-7-5-16(8-2-4-10(18)15-12(8)19)13(20)6(7)1-3-9(11)17/h1,3,8,17H,2,4-5,14H2,(H,15,18,19)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:09:52 UTC 2023` Edited by `admin` on `Sat Dec 16 10:09:52 UTC 2023`
Record UNII	LB9TF67ZH6
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

5-HYDROXY-LENALIDOMIDE

Common Name

English

2,6-PIPERIDINEDIONE, 3-(4-AMINO-1,3-DIHYDRO-5-HYDROXY-1-OXO-2H-ISOINDOL-2-YL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

LB9TF67ZH6

Created by admin on Sat Dec 16 10:09:52 UTC 2023 , Edited by admin on Sat Dec 16 10:09:52 UTC 2023

PRIMARY

CAS

1421593-78-3

Created by admin on Sat Dec 16 10:09:52 UTC 2023 , Edited by admin on Sat Dec 16 10:09:52 UTC 2023

PRIMARY

PUBCHEM

91224064

Created by admin on Sat Dec 16 10:09:52 UTC 2023 , Edited by admin on Sat Dec 16 10:09:52 UTC 2023

PRIMARY

Related Record Type Details


					F0P408N6V4

PARENT -> METABOLITE

Comments:

Metabolites are hydroxy-lenalidomide and N-acetyl-lenalidomide; each constitutes less than 5% of parent levels in circulation.

Qualification:

FECAL; PLASMA; URINE

Amount: